Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

计划入组 1,979 人 · 首次发布于 2006 年 10 月 4 日

Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets

计划入组 32 人 · 首次发布于 2024 年 7 月 3 日

S-32 PG 242 Short Stem

计划入组 45 人 · 首次发布于 2021 年 10 月 19 日

SM-32

A-32

CU-32

Kowa Research Institute, Inc.

United States

TERSERA THERAPEUTICS LLC

United States

Zenas BioPharma (USA) LLC

United States

Johns Hopkins Study Links Hypoglycemia to Diabetic Retinopathy Progression, Experimental Drug Shows Promise

AAO 2024 Highlights: Aging Clinicians, Presbyopia Drop, Modern Anesthesia, and AMD Advancements

Recent Pipeline Activity: Key Approvals and Phase III Readouts in Pharmaceuticals